Diagnosis & Disease Information

Colby Stong

September 13, 2021

Researchers sought to determine whether tafasitamab with lenalidomide would improve outcomes for patients with relapsed/refractory DLBCL.

Sucharita Mistry, PhD

September 11, 2021

Survival outcomes were comparable for patients who received tisagenlecleucel and those who received lisocabtagene maraleucel.

Leah Lawrence

August 30, 2021

Response and survival outcomes were similar with rituximab biosimilars and the originator.

Patricia Chaney

October 15, 2020

Pregnant patients with non-Hodgkin lymphoma may be able to receive CHOP-like chemotherapy during pregnancy with some risks.

Next post in Lymphoma

Maternal, Fetal Considerations for the Treatment and Management of Lymphoma During Pregnancy